Year : 2021  |  Volume : 14  |  Issue : 2  |  Page : 170--177

A prospective randomized clinical study of perioperative oral thyroid hormone treatment for children undergoing surgery for congenital heart diseases


Alok Kumar1, Nikhil Tiwari2, H Ravi Ramamurthy3, Vivek Kumar3, Gaurav Kumar4 
1 Department of Cardiothoracic Anaesthesia, Army Hospital R&R, New Delhi, India
2 Department of Cardiothoracic Surgery, Army Hospital R&R, New Delhi, India
3 Department of Pediatric Cardiology & Grown Up Congenital Heart Diseases, Army Hospital R&R, New Delhi, India
4 Department of Pediatric Cardiothoracic Surgery, Fortis Escorts Heart Institute, New Delhi, India

Correspondence Address:
Dr. H Ravi Ramamurthy
Department of Pediatric Cardiology & Grown Up Congenital Heart Diseases, Army Hospital R&R, Delhi Cantonment, New Delhi - 110 010
India

Context : Thyroid hormone deficiency is known to occur after cardiac surgery and known as nonthyroid illness (NTI). The beneficial role perioperative thyroid hormone supplementation in children has been debatable more so with oral supplementation. Aims : The aim is to evaluate the role of pre-operative oral thyroid hormone therapy in preventing NTI. To assess its effect on post-operative thyroid hormone levels, hemodynamic parameters, and cardiac function of infants and small children undergoing pediatric cardiac surgery. Settings and Design : Prospective randomized, double-blinded controlled trial at a tertiary level pediatric cardiothoracic center. Materials and Methods : Sixty-five children aged under 18 months undergoing corrective surgeries on cardiopulmonary bypass were included. Patients were randomized into two equal groups: placebo group (given placebo) and thyroxine group (given thyroxine tablet 10 μg/kg) orally once a day starting on the preoperative evening till the fifth postoperative day. The postoperative hemodynamics, inotropic requirement, ventilatory requirement, and cardiac function on echocardiography were observed. Statistical Tests : Shapiro–Wilk test, Mann–Whitney/t-test, Chi-square test, ANOVA with Tukey correction were used. Results : Serum triiodothyronine and thyroxine levels postoperatively were significantly higher in the thyroxine group than in the placebo group. There was no significant difference in left ventricular ejection fraction, hemodynamic variables, extubation time, and length of intensive care unit (ICU) stay between the two groups. Conclusions : In infants and small children undergoing corrective cardiac surgery, perioperative oral thyroid hormone therapy reduces the severity of postoperative NTI. It increases the serum level of thyroid hormones but the therapy does not translate to better hemodynamics, reduced inotropic requirement, reduced ventilatory requirement, improved myocardial function or reduced ICU stay when compared to placebo.


How to cite this article:
Kumar A, Tiwari N, Ramamurthy H R, Kumar V, Kumar G. A prospective randomized clinical study of perioperative oral thyroid hormone treatment for children undergoing surgery for congenital heart diseases.Ann Pediatr Card 2021;14:170-177


How to cite this URL:
Kumar A, Tiwari N, Ramamurthy H R, Kumar V, Kumar G. A prospective randomized clinical study of perioperative oral thyroid hormone treatment for children undergoing surgery for congenital heart diseases. Ann Pediatr Card [serial online] 2021 [cited 2022 Nov 28 ];14:170-177
Available from: https://www.annalspc.com/article.asp?issn=0974-2069;year=2021;volume=14;issue=2;spage=170;epage=177;aulast=Kumar;type=0